Heterologous Boost Immunization with Ad5-nCoV After Three-dose Priming with an Inactivated SARS-CoV-2 Vaccine
Clinical trial NCT05303584 · COMPLETED
Trial details
- NCT number
- NCT05303584
- Sponsor
- Jiangsu Province Centers for Disease Control and Prevention
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-23
- Primary completion
- 2022-06-20
- Enrollment
- 362
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.